Marianna Cavazza
Biographic Data
| ID | 4384770 |
|---|---|
| NAME | Marianna Cavazza |
| GIVEN NAMES | Marianna |
| FAMILY NAME | Cavazza |
| SIGNATURE | CAVAZZA M |
| AFFILIATIONS | Bocconi University |
| ORCID | 0000-0001-5609-6804 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 6 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Geographical variation in the use of private health insurance in a predominantly publicly-funded system
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases
In the field of rare diseases (RDs), the evidence standard is often lower than that required by health technology assessment (HTA) and payer authorities. In this commentary, we propose that appropriate economic evaluation for rare disease treatments should be initially informed by cost-of-illness (COI) studies conducted using a societal perspective. Such an approach contributes to improving countries' understanding of RDs in their entirety as soc…
Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome
Background : Cri du Chat syndrome (CdC) is a rare disease caused by the deletion on the short arm of the chromosome 5, with an incidence of 1:15,000 to 1:50,000 live-born infants. No study at international level has assessed the costs, Quality of Life (QoL) and Disability through standardized quantitative tools. The aim is to estimate economic costs related to CdC from a societal perspective, to assess the QoL and Disability in patients with CdC …
Governing through Evidence
The evidence-based paradigm is increasingly permeating the spheres of policymaking and management in health care, as it has in most other public domains. An emerging stream of research has investigated how different institutional arrangements are more (or less) conducive to an effective evidence-based policy. We contribute to this stream through a multiple-case design on governing technological innovation. In particular, the study examines the dy…
Governing through Evidence
The evidence-based paradigm is increasingly permeating the spheres of policymaking and management in health care, as it has in most other public domains. An emerging stream of research has investigated how different institutional arrangements are more (or less) conducive to an effective evidence-based policy. We contribute to this stream through a multiple-case design on governing technological innovation. In particular, the study examines the dy…
Governing through Evidence
The evidence-based paradigm is increasingly permeating the spheres of policymaking and management in health care, as it has in most other public domains. An emerging stream of research has investigated how different institutional arrangements are more (or less) conducive to an effective evidence-based policy. We contribute to this stream through a multiple-case design on governing technological innovation. In particular, the study examines the dy…
Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome
Background : Cri du Chat syndrome (CdC) is a rare disease caused by the deletion on the short arm of the chromosome 5, with an incidence of 1:15,000 to 1:50,000 live-born infants. No study at international level has assessed the costs, Quality of Life (QoL) and Disability through standardized quantitative tools. The aim is to estimate economic costs related to CdC from a societal perspective, to assess the QoL and Disability in patients with CdC …
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases
In the field of rare diseases (RDs), the evidence standard is often lower than that required by health technology assessment (HTA) and payer authorities. In this commentary, we propose that appropriate economic evaluation for rare disease treatments should be initially informed by cost-of-illness (COI) studies conducted using a societal perspective. Such an approach contributes to improving countries' understanding of RDs in their entirety as soc…
Geographical variation in the use of private health insurance in a predominantly publicly-funded system
Economics (3 works) · Health care (3 works) · Medicine (3 works) · Business (2 works) · Environmental health (2 works) · Population (2 works) · Public economics (2 works) · Activity-based costing (1 work) · Archetype (1 work) · Artificial Intelligence (1 work)